Search results
23andMe Fiscal Q4 Revenues Drop 31 Percent as Research Services, Genetic Test Kit Sales Shrink
GenomeWeb News· 6 hours agoThe firm attributed the decrease largely to lower research services revenue due to ending a collaboration with GlaxoSmithKline, as well as lower consumer services revenue ...
GlaxoSmithKline Pharma India posts higher Q4 adjusted profit on strong sales
Reuters· 7 days ago, opens new tab reported a 49% rise in fourth-quarter adjusted profit on Friday, as strong demand for its generic medicines offset the impact of the government's ongoing price
Abbott India Brushes Off Govt Caps To Post Strong Q4 Print, Shares Gain
Investing.com· 2 weeks agoShares of drugmaker Abbott India (NS: ABOT ) were rising on Friday after the company posted strong...
GSK Discovered Vaccine That Protects Against RSV, Paul Singer
Dealbreaker· 2 days agoPaul Singer may or may not have become a nicer person over the last few years, but that doesn’t mean...
Tempus, Chicago's biotech darling, files to go public
Crain s Chicago Business· 3 days agoAfter several rounds of investment from venture-capital and private-equity investors, Tempus became a Chicago tech darling with a valuation north of $8 billion in 2020. Now ...
Marti Technologies names new CFO By Investing.com
Investing.com· 6 days agoMarti Technologies, Inc. (NYSE American: MRT), a prominent mobility service provider in Türkiye, today announced the appointment of Oguz Erkan as its new...
Court backs drugmakers in limiting 340B distribution
Becker’s Hospital Review· 2 days agoThree judges for the U.S. Court of Appeals for the Washington, D.C. Circuit ruled May 21 in favor of drug manufacturers' ability to limit sales and distribution of discounted ...
